John B. Liao

1.4k total citations
43 papers, 933 citations indexed

About

John B. Liao is a scholar working on Reproductive Medicine, Oncology and Immunology. According to data from OpenAlex, John B. Liao has authored 43 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Reproductive Medicine, 20 papers in Oncology and 16 papers in Immunology. Recurrent topics in John B. Liao's work include Ovarian cancer diagnosis and treatment (20 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (10 papers). John B. Liao is often cited by papers focused on Ovarian cancer diagnosis and treatment (20 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (10 papers). John B. Liao collaborates with scholars based in United States, Canada and China. John B. Liao's co-authors include Daniel DiMaio, Ennapadam Venkatraman, Larry Léon, S. Dennis, Martee L. Hensley, W.J. Hoskins, Catalin S. Buhimschi, Errol R. Norwitz, Mary L. Disis and Barbara A. Goff and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

John B. Liao

42 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John B. Liao United States 18 432 313 267 253 188 43 933
Ingolf Juhasz‐Böss Germany 15 194 0.4× 226 0.7× 219 0.8× 152 0.6× 179 1.0× 87 845
William H. Bradley United States 17 348 0.8× 365 1.2× 269 1.0× 108 0.4× 90 0.5× 78 1.0k
Jiří Špaček Czechia 15 370 0.9× 130 0.4× 526 2.0× 166 0.7× 122 0.6× 59 1.1k
Yeh Chen Lee Australia 13 227 0.5× 205 0.7× 318 1.2× 91 0.4× 70 0.4× 51 791
Giovanni Delli Carpini Italy 20 449 1.0× 607 1.9× 132 0.5× 192 0.8× 86 0.5× 92 1.2k
Liron Kogan Israel 15 221 0.5× 252 0.8× 138 0.5× 155 0.6× 40 0.2× 56 649
Giovanni Di Vagno Italy 17 435 1.0× 370 1.2× 340 1.3× 349 1.4× 39 0.2× 52 1.1k
Louise Baandrup Denmark 16 303 0.7× 226 0.7× 225 0.8× 347 1.4× 75 0.4× 47 1.1k
Heung‐Tat Ng Taiwan 16 277 0.6× 249 0.8× 81 0.3× 144 0.6× 122 0.6× 35 729
Haldun Güner Türkiye 15 258 0.6× 251 0.8× 72 0.3× 130 0.5× 82 0.4× 55 664

Countries citing papers authored by John B. Liao

Since Specialization
Citations

This map shows the geographic impact of John B. Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Liao more than expected).

Fields of papers citing papers by John B. Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Liao. The network helps show where John B. Liao may publish in the future.

Co-authorship network of co-authors of John B. Liao

This figure shows the co-authorship network connecting the top 25 collaborators of John B. Liao. A scholar is included among the top collaborators of John B. Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John B. Liao. John B. Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, John B., et al.. (2025). The Role of SWI/SNF Complex in Bladder Cancer. Journal of Cellular and Molecular Medicine. 29(1). e70348–e70348. 2 indexed citations
2.
3.
4.
Liao, John B., William R. Gwin, Yushe Dang, et al.. (2024). Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer. Gynecologic Oncology. 191. 74–79. 1 indexed citations
5.
Dao, Minh, Emese Zsíros, Renata R. Urban, et al.. (2023). Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study. European Journal of Gynaecological Oncology. 44(1). 17–25. 6 indexed citations
6.
Disis, Mary L., Sarah F. Adams, Jyoti Bajpai, et al.. (2023). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. Journal for ImmunoTherapy of Cancer. 11(6). e006624–e006624. 14 indexed citations
7.
8.
Kohrn, Brendan F., Jeanne Fredrickson, Marc R. Radke, et al.. (2022). Uterine Lavage Identifies Cancer Mutations and Increased TP53 Somatic Mutation Burden in Individuals with Ovarian Cancer. Cancer Research Communications. 2(10). 1282–1292. 9 indexed citations
9.
Disis, Mary L., Ying Liu, Sasha E. Stanton, et al.. (2022). 546 A phase I dose escalation study of STEMVAC, a multi-antigen, multi-epitope Th1 selective plasmid-based vaccine, targeting stem cell associated proteins in patients with advanced breast cancer. Regular and Young Investigator Award Abstracts. A571–A571. 10 indexed citations
10.
Cecil, Denise L., John B. Liao, Yushe Dang, et al.. (2021). Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses. Clinical Cancer Research. 27(23). 6405–6412. 11 indexed citations
11.
Liao, John B., William R. Gwin, Renata R. Urban, et al.. (2021). Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates. Journal for ImmunoTherapy of Cancer. 9(9). e003122–e003122. 17 indexed citations
12.
Shah, Chirag, et al.. (2017). Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer. Journal of Gynecologic Oncology. 28(6). e82–e82. 88 indexed citations
13.
Liao, John B., Ron E. Swensen, Leonard D’Amico, et al.. (2017). Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer. Gynecologic Oncology. 144(3). 480–485. 13 indexed citations
14.
Goff, Barbara A., Kathy Agnew, Moni B. Neradilek, et al.. (2017). Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass. Gynecologic Oncology. 147(2). 291–295. 34 indexed citations
15.
Liao, John B., et al.. (2015). Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer. Journal for ImmunoTherapy of Cancer. 3(1). 16–16. 23 indexed citations
16.
Liao, John B., et al.. (2015). Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates. Gynecologic Oncology. 137(3). 430–435. 34 indexed citations
17.
Robinson, Barbara, John B. Liao, Sarah F. Adams, & Thomas C. Randall. (2009). Vaginal Cuff Dehiscence After Robotic Total Laparoscopic Hysterectomy. Obstetrics and Gynecology. 114(2). 369–371. 47 indexed citations
18.
Kandalaft, Lana E., Nathan Singh, John B. Liao, et al.. (2009). The emergence of immunomodulation: Combinatorial immunochemotherapy opportunities for the next decade. Gynecologic Oncology. 116(2). 222–233. 25 indexed citations
19.
DiMaio, Daniel & John B. Liao. (2006). Human Papillomaviruses and Cervical Cancer. Advances in virus research. 66. 125–159. 46 indexed citations
20.
Dennis, S., John B. Liao, Larry Léon, et al.. (2001). Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma. Gynecologic Oncology. 82(3). 532–537. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingolf Juhasz‐Böss Breakdown of academic impact, for papers by William H. Bradley Breakdown of academic impact, for papers by Jiří Špaček Breakdown of academic impact, for papers by Yeh Chen Lee Breakdown of academic impact, for papers by Giovanni Delli Carpini Breakdown of academic impact, for papers by Liron Kogan Breakdown of academic impact, for papers by Giovanni Di Vagno Breakdown of academic impact, for papers by Louise Baandrup Breakdown of academic impact, for papers by Heung‐Tat Ng Breakdown of academic impact, for papers by Haldun Güner
Rankless by CCL
2026